TY - JOUR
T1 - Safety of catheter ablation of atrial fibrillation using fiber optic–based contact force sensing
AU - Mansour, Moussa
AU - Lakkireddy, Dhanunjaya
AU - Packer, Douglas
AU - Day, John D.
AU - Mahapatra, Srijoy
AU - Brunner, Kyle
AU - Reddy, Vivek
AU - Natale, Andrea
N1 - Funding Information:
We thank Elizabeth Obringer, and Claude Rickerd, from Abbott for their assistance in providing the data that made this analysis possible.
Publisher Copyright:
© 2017 Heart Rhythm Society
PY - 2017/11
Y1 - 2017/11
N2 - Background While the body of evidence showing the benefit of contact force (CF)–sensing catheters in improving atrial fibrillation ablation success rate is growing, real-world safety data of this technology are limited. Objective The aim of this study was to report the complication rate in patients undergoing ablation using a specific CF-sensing catheter (TactiCath Quartz CF ablation catheter, Abbott, St. Paul, MN) in a large worldwide database. Methods User-reported adverse event data from January 1, 2014 to December 31, 2015 were reviewed for the ablation catheter. These adverse events included cardiac perforation, cerebrovascular accident, atrioesophageal (AE) fistula, steam pop, and death. Rates of these adverse events, including geographic and temporal relationships, were calculated. Results Adverse events were reported in 178 of 41,709 patients (adverse event rate 0.427%). Adverse events included 117 cardiac perforations (0.281%), 5 cerebrovascular accidents (0.012%), 10 AE fistulas (0.024%), 53 audible steam pops (0.127%), and 13 deaths (0.031%). The total event rate in European countries was 0.53% vs 0.38% in the United States (P =.0082). The AE fistula event rate peaked in late 2014 and early 2015 at 0.06% and decreased over time to a steady-state 0.01%, corresponding to the initial US release, subsequent increased use, and training on the manufacturer recommended settings. Conclusion Complication rates while using the TactiCath CF ablation catheter appear to decrease with training and experience. The major complication rate associated with this technology is low in the context of similar reports of conventional radiofrequency catheters.
AB - Background While the body of evidence showing the benefit of contact force (CF)–sensing catheters in improving atrial fibrillation ablation success rate is growing, real-world safety data of this technology are limited. Objective The aim of this study was to report the complication rate in patients undergoing ablation using a specific CF-sensing catheter (TactiCath Quartz CF ablation catheter, Abbott, St. Paul, MN) in a large worldwide database. Methods User-reported adverse event data from January 1, 2014 to December 31, 2015 were reviewed for the ablation catheter. These adverse events included cardiac perforation, cerebrovascular accident, atrioesophageal (AE) fistula, steam pop, and death. Rates of these adverse events, including geographic and temporal relationships, were calculated. Results Adverse events were reported in 178 of 41,709 patients (adverse event rate 0.427%). Adverse events included 117 cardiac perforations (0.281%), 5 cerebrovascular accidents (0.012%), 10 AE fistulas (0.024%), 53 audible steam pops (0.127%), and 13 deaths (0.031%). The total event rate in European countries was 0.53% vs 0.38% in the United States (P =.0082). The AE fistula event rate peaked in late 2014 and early 2015 at 0.06% and decreased over time to a steady-state 0.01%, corresponding to the initial US release, subsequent increased use, and training on the manufacturer recommended settings. Conclusion Complication rates while using the TactiCath CF ablation catheter appear to decrease with training and experience. The major complication rate associated with this technology is low in the context of similar reports of conventional radiofrequency catheters.
KW - Atrial fibrillation
KW - Atrioesophageal fistula
KW - Catheter ablation
KW - Complications
KW - Contact force
UR - http://www.scopus.com/inward/record.url?scp=85028459613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028459613&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2017.07.023
DO - 10.1016/j.hrthm.2017.07.023
M3 - Article
C2 - 28734985
AN - SCOPUS:85028459613
SN - 1547-5271
VL - 14
SP - 1631
EP - 1636
JO - Heart rhythm
JF - Heart rhythm
IS - 11
ER -